About Us
Leo Greenstein
Chief Financial Officer
Leo has more than 20 years of business experience within the life sciences and technology sectors. Prior to joining Tarsus, he was Senior Vice President of Finance & Corporate Controller at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) where he was responsible for leading all aspects of their financial planning & analysis, treasury management, accounting operations, stock-plan administration, tax planning and compliance, and SEC reporting. Leo has played significant roles in the assessment and completion of numerous capital raises, investor relations and business development activities. In addition, he has recruited and developed high-performing accounting and finance teams in the U.S. and Europe, designed business processes that are efficient, scalable, and SOX compliant, and has implemented a variety of IT systems that have enhanced finance and accounting capabilities.
Prior to joining Spectrum in 2013, Mr. Greenstein served as Vice President of Finance & Corporate Controller with Endologix, Inc. (NASDAQ: ELGX), Senior Director of Finance at Clarient, Inc. (NASDAQ: CLRT, acquired by GE Healthcare in December 2010), and Assistant Controller at Safeguard Scientifics, Inc. (NYSE: SFE).
He earned his B.A. in Accounting from Arcadia University in Glenside, Pennsylvania and his J.D. from Temple University, and is a Certified Public Accountant (license active in California) and admitted to the State Bar of California.